Bot Detector
Download FREE Sample Issue or Article
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications

Author(s):  Gilbert John A

Issue:  Sep/Oct 2009 - Veterinary Compounding
View All Articles in Issue

Abstract:  The practice of pharmaceutical compounding may involve the dispensing of controlled substances, a subset of prescription drug products. In such cases, the Drug Enforcement Administration has authority to regulate and enforce pharmacy compounding in the U.S. through the Controlled Substances Act and Drug Enforcement Administration regulations, although the Drug Enforcement Administration expressly acknowledges that the agency does not establish medical standards or guidelines on the treatment of pain. There is a need to balance the interests of law enforcement in reducing the potential for prescription drug abuse without adversely affecting the need to ensure appropriate availability and access to pain medicine. Compounding pharmacies provide an important service to practitioners and their patients suffering from chronic pain and debilitating illness. Without access to pain medicine, a patient’s needs would go unmet, resulting in unnecessary pain and suffering.

Related Keywords: John A. Gilbert, Jr., Esq, prescription drug abuse, controlled substances, U.S. Drug Enforcement Administration, DEA, law enforcement, Model Guidelines, pain medication, medical practice standards, online pharmacy, internet

Related Categories: LEGAL, PAIN MANAGEMENT

Printer-Friendly Version

Download in electronic PDF format for $55

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications Gilbert John A Sep/Oct 2009 400-403 Buy
Veterinary Transdermal Medications: A to Z Davidson Gigi S Mar/Apr 2003 106-113 Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr Jul/Aug 2016 351 View Sample
The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act Pore R David Nov/Dec 2012 446-450 Buy
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Williams LaVonn A Nov/Dec 2011 526-527 Buy
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr Sep/Oct 2017 356 Buy
U.S. Food and Drug Administration Inspection Authority: How to Know Whether U.S. Food and Drug Administration Inspectors Are Crossing the Line Snow Stephen T, Stannard Robert W, Bellis Jennifer, Moss Carrie A Jan/Feb 2019 32-33 Buy
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G Jul/Aug 2015 303-305 Buy
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies Yoch Doug Mar/Apr 2017 95-102 Buy
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr Nov/Dec 2015 487-488 Buy